Furthermore, lymphocytes from patients with homozygous FH can effectively take up Lp(a) particles, and PCSK9 inhibitors can lower circulating Lp(a) in homozygous FH patients (56), indicating a LDLR-independent pathway. This evidence concerns the gene LDLR and familial hyperaldosteronism.